Related Experiment Videos
Novel activation of STAT5b in response to epidermal growth factor
Michael T Kloth1, Andrew D Catling, Corinne M Silva
1Department of Internal Medicine, University of Virginia Health System, Charlottesville, Virginia 22908, USA.
Abstract:
Of the seven signal transducers and activators of transcription that have been identified, STATs 1, 3, and 5a/5b can be activated not only by a multitude of cytokines but also by some growth factors. The data presented here demonstrate that, in contrast to activation by the cytokine, growth hormone (GH), the activation of STAT5b by the growth factor, epidermal growth factor (EGF), requires overexpression of the EGF receptor (EGFR). We have shown that EGF activates STAT5b not only in a HEK293 cell model in which the EGFR is stably overexpressed but also in the MDA-MB468 breast cancer cell line. Furthermore, EGF (but not GH) is able to activate tyrosine phosphorylation of a Tyr-699 mutant of STAT5b. Using metabolic labeling studies as well as site-directed mutagenesis, we have identified three novel EGF-induced tyrosine phosphorylation sites, Tyr-725, Tyr-740, and Tyr-743. Luciferase assays using a STAT5-specific DNA sequence demonstrate that, although Tyr-699 is absolutely required for transcriptional activation, tyrosines 725, 740, and 743 may be involved in a negative regulation of transcription. Because overexpression of the EGFR is common in many cancers, including advanced breast cancer, characterization of EGF-induced STAT5b may have direct implications in therapeutic applications.
Insights
Epidermal growth factor (EGF) activates STAT5b, but requires epidermal growth factor receptor (EGFR) overexpression. Novel phosphorylation sites on STAT5b were identified, impacting gene transcription, with implications for breast cancer therapy.
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Research
Background:
- Signal transducers and activators of transcription (STATs) are crucial in cellular signaling.
- STATs 1, 3, and 5a/5b are activated by cytokines and growth factors.
- STAT5b activation mechanisms by growth factors are less understood than cytokine-mediated activation.
Purpose of the Study:
- To investigate the mechanism of STAT5b activation by epidermal growth factor (EGF).
- To identify novel EGF-induced phosphorylation sites on STAT5b.
- To explore the role of these sites in STAT5b transcriptional activity and their relevance to cancer.
Main Methods:
- Utilized HEK293 cells with stably overexpressed EGF receptor (EGFR) and MDA-MB-468 breast cancer cells.
- Employed site-directed mutagenesis to study tyrosine phosphorylation mutants of STAT5b (Tyr-699, Tyr-725, Tyr-740, Tyr-743).
- Performed metabolic labeling and luciferase assays to assess STAT5b phosphorylation and transcriptional activity.
Main Results:
- EGF activates STAT5b, but this requires EGFR overexpression, unlike growth hormone (GH) activation.
- Identified three novel EGF-induced tyrosine phosphorylation sites on STAT5b: Tyr-725, Tyr-740, and Tyr-743.
- Tyr-699 is essential for STAT5b transcriptional activation, while Tyr-725, Tyr-740, and Tyr-743 may negatively regulate transcription.
Conclusions:
- EGF-induced STAT5b activation is dependent on EGFR levels.
- Novel phosphorylation sites on STAT5b are identified, influencing its transcriptional function.
- Understanding EGF-induced STAT5b signaling, especially in EGFR-overexpressing cancers like breast cancer, has therapeutic potential.